[
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each SNP, we used logistic regression analysis to estimate the per-allele interaction odds ratio (IOR), a measure of departure from a multiplicative joint effect of the SNP and chest RT, for the risk of breast cancer, assuming independence between chest RT and the SNP in women from the general population.31\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, we used a 2-step design to identify susceptibility variants for radiation-induced breast cancer (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).PRS based on known breast cancer SNPs (case-control analysis)\nTo evaluate the combined effect of known breast cancer SNPs, we studied a BC-PRS containing 76 SNPs that increase breast cancer risk in the general population30 in chest-irradiated HL survivors.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "SNPs interacting with RT on breast cancer risk (case-only analysis)\nWe tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We tested 194 106 SNPs that passed quality control for an interaction with chest RT in the case-only analysis of breast cancer patients (QQ plot is depicted in supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The RT-interaction-PRS increased breast cancer risk after chest RT for HL with ORs of 1.2 (95% CI, 0.8-1.7; P = .348) and 1.6 (95% CI, 1.1-2.4; P = .007), respectively, for the middle and highest tertiles compared with the lowest tertile, adjusted for age and year of HL diagnosis, country, ethnicity, and the BC-PRS (Figure 2; supplemental Table 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of note, rs10505506 is not in LD (r2 < 0.3 in Europeans from the 1000 Genomes Project38) with previously identified cancer risk variants in the PVT1 locus (supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The ORs for developing breast cancer after chest RT for HL by deciles of the BC-PRS, compared with women in the middle quintile (40th to 60th percentile), are shown in Figure 3 and supplemental Table 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]